Skip to main content

Table 2 Patient characteristics. Data are shown as mean ± SD or counts (%)

From: Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation

Characteristic

Total

N = 86

IM HBIG

N = 59

IV HBIG

N = 27

P value*

Gender

   

0.13

 Male

68 (79.1)

44 (74.6)

24 (88.9)

 

 Female

18 (20.9)

15 (25.4)

3 (11.1)

 

Age

56.6 ± 10.3

55.8 ± 10.8

58.4 ± 9.0

0.41

Occupation

   

0.04

 Employed, full time/part time

25 (29.1)

21 (35.6)

4 (15.4)

 

 Unemployed

6 (7.0)

4 (6.8)

2 (7.7)

 

 Retired

41 (47.7)

25 (42.4)

16 (61.5)

 

 Housewife

11 (12.8)

9 (15.3)

2 (7.7)

 

 Other

3 (3.5)

0 (0.0)

2 (7.7)

 

Years of school education

   

0.58

 ≤ 5 years

26 (30.2)

18 (31.0)

8(30.8)

 

 6–8 years

27 (31.4)

18 (31.0)

9 (34.6)

 

 9–13 years

27 (31.4)

18 (31.0)

9 (34.6)

 

 > 13 years

4 (4.7)

4 (4.9)

0 (0.0)

 

 Not reported

2 (2.3)

1 (1.7)

1 (3.7)

 

Marital status

   

0.20

 Single

15 (17.4)

13 (22.0)

2 (7.7)

 

 Married

61 (70.9)

39 (66.1)

22 (84.6)

 

 Divorced/widowed

9 (10.6)

7 (11.9)

2 (7.6)

 

 Not reported

1 (1.2)

0 (0.0%)

1 (3.8)

 

Living alone

13 (15.1)

12 (20.7)

1 (3.8)

0.06

Years after LT

8.5 ± 5.9

8.6 ± 5.9

8.3 ± 6.1

0.72

Previous hepatocellular carcinoma

31 (36.0)

21 (36.8)

10 (37.0)

0.98

Diabetes

18 (20.9)

13 (22.0)

5 (18.5)

0.71

Hypertension

31 (36.0)

22 (37.3)

9 (33.3)

0.72

Obesity

11 (12.8)

10 (16.9)

1 (3.7)

0.16

  1. HBIG hepatitis B immunoglobulin, IM intramuscular, IV intravenous, LT liver transplantation
  2. *P value for IM versus IV HBIG (Mann-Whitney U-test for continuous variables; chi square or Fisher exact test for categorical variables)